Vigabatrin Tablet, Film Coated
Product Images NDC 0591-3851

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 0591-3851). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
FDA Label Image

1 (Image 2)

1 (Image 2)
FDA Label Image

Figure 2. Percent Reduction From Baseline In Seizure Frequency (Image 3)

Figure 2. Percent Reduction From Baseline In Seizure Frequency (Image 3)
FDA Label Image

1 (Image 4)

1 (Image 4)
This is a medication label for Vigabatrin Tablets, USP, with a potency of 500 mg. The label includes instructions for dispensing the accompanying medication guide, and to store the tablets at room temperature. Vigabalin, USP is the active ingredient, and dosage information can be found in the accompanying product information. The medication should be dispensed in a light-resistant container and kept out of the reach of children. The text includes manufacturing information for Vialson Pharma Pvt Limited located in India, and Tova Pharmaceuticals USA is the manufacturer. The label includes a lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.